Effect of Time Since Heart Failure Diagnosis or Hospitalization on the Cost-Effectiveness of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

ANKEET S. BHATT; RUDOLF A. DE BOER; DAVID BOOTH; JASON A. DAVIS; T. O.R.U. KONDO; PARDEEP JHUND; JIELING CHEN

doi:10.1016/j.cardfail.2025.06.014

Effect of Time Since Heart Failure Diagnosis or Hospitalization on the Cost-Effectiveness of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

ANKEET S. BHATT^*, RUDOLF A. DE BOER, DAVID BOOTH, JASON A. DAVIS, T. O.R.U. KONDO, PARDEEP JHUND, JIELING CHEN

^*Corresponding author for this work

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1598-1600
Number of pages	3
Journal	Journal of Cardiac Failure
Volume	31
Issue number	10
DOIs	https://doi.org/10.1016/j.cardfail.2025.06.014
Publication status	Published - Oct 2025

Access to Document

10.1016/j.cardfail.2025.06.014

Cite this

BHATT, ANKEET. S., DE BOER, RUDOLF. A., BOOTH, DAVID., DAVIS, JASON. A., KONDO, T. O. R. U., JHUND, PARDEEP., & CHEN, JIELING. (2025). Effect of Time Since Heart Failure Diagnosis or Hospitalization on the Cost-Effectiveness of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction. Journal of Cardiac Failure, 31(10), 1598-1600. https://doi.org/10.1016/j.cardfail.2025.06.014

@article{a498698fa7f54276b9609651a6d9052d,

title = "Effect of Time Since Heart Failure Diagnosis or Hospitalization on the Cost-Effectiveness of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction",

author = "BHATT, \{ANKEET S.\} and \{DE BOER\}, \{RUDOLF A.\} and DAVID BOOTH and DAVIS, \{JASON A.\} and KONDO, \{T. O.R.U.\} and PARDEEP JHUND and JIELING CHEN",

year = "2025",

month = oct,

doi = "10.1016/j.cardfail.2025.06.014",

language = "English",

volume = "31",

pages = "1598--1600",

journal = "Journal of Cardiac Failure",

issn = "1071-9164",

publisher = "Elsevier",

number = "10",

}

BHATT, ANKEETS, DE BOER, RUDOLFA, BOOTH, DAVID, DAVIS, JASONA, KONDO, TORU, JHUND, PARDEEP & CHEN, JIELING 2025, 'Effect of Time Since Heart Failure Diagnosis or Hospitalization on the Cost-Effectiveness of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction', Journal of Cardiac Failure, vol. 31, no. 10, pp. 1598-1600. https://doi.org/10.1016/j.cardfail.2025.06.014

Effect of Time Since Heart Failure Diagnosis or Hospitalization on the Cost-Effectiveness of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction. / BHATT, ANKEET S.; DE BOER, RUDOLF A.; BOOTH, DAVID et al.
In: Journal of Cardiac Failure, Vol. 31, No. 10, 10.2025, p. 1598-1600.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Effect of Time Since Heart Failure Diagnosis or Hospitalization on the Cost-Effectiveness of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

AU - BHATT, ANKEET S.

AU - DE BOER, RUDOLF A.

AU - BOOTH, DAVID

AU - DAVIS, JASON A.

AU - KONDO, T. O.R.U.

AU - JHUND, PARDEEP

AU - CHEN, JIELING

PY - 2025/10

Y1 - 2025/10

UR - https://www.scopus.com/pages/publications/105017760307

U2 - 10.1016/j.cardfail.2025.06.014

DO - 10.1016/j.cardfail.2025.06.014

M3 - Article

C2 - 40759248

AN - SCOPUS:105017760307

SN - 1071-9164

VL - 31

SP - 1598

EP - 1600

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

IS - 10

ER -

BHATT ANKEETS, DE BOER RUDOLFA, BOOTH DAVID, DAVIS JASONA, KONDO TORU, JHUND PARDEEP et al. Effect of Time Since Heart Failure Diagnosis or Hospitalization on the Cost-Effectiveness of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction. Journal of Cardiac Failure. 2025 Oct;31(10):1598-1600. doi: 10.1016/j.cardfail.2025.06.014

Effect of Time Since Heart Failure Diagnosis or Hospitalization on the Cost-Effectiveness of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Access to Document

Other files and links

Embargoed Document

Cite this